The Vanguard Group 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 2,312,786 7.090% |
104,675 (+4.74%) |
Filing |
| 2023-02-09 11:16 am Sale |
2022-12-30 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 2,208,111 6.580% |
-79,306 (-3.47%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 2,287,417 6.620% |
556,565 (+32.16%) |
Filing |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 1,730,852 5.010% |
50,198 (+2.99%) |
Filing |